Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67

BACKGROUND: Despite evidence of different malignant potentials, postoperative follow-up assessment is similar for G1 and G2 pancreatic neuroendocrine tumors (panNETs) and adjuvant treatment currently is not indicated. This study investigated the role of Ki67 with regard to recurrence and survival af...

Descripción completa

Detalles Bibliográficos
Autores principales: Genç, C. G., Falconi, M., Partelli, S., Muffatti, F., van Eeden, S., Doglioni, C., Klümpen, H. J., van Eijck, C. H. J., Nieveen van Dijkum, E. J. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Pancreatic Tumors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028862/
https://www.ncbi.nlm.nih.gov/pubmed/29789972
http://dx.doi.org/10.1245/s10434-018-6518-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028862/
https://www.ncbi.nlm.nih.gov/pubmed/29789972
http://dx.doi.org/10.1245/s10434-018-6518-2

Ejemplares similares